Medical Weight Loss Rockville Maryland

Semaglutide targets GLP-1 receptors, while tirzepatide targets both GLP-1 and GIP receptors, often resulting in greater weight loss. Clinical studies show tirzepatide patients typically achieve 15-20% body weight reduction, while semaglutide patients average 10-15% weight loss. Dr. Nawrocki will determine which medication is most appropriate based on your health profile and weight loss goals.

Clinical studies show significant weight loss potential with GLP-1 medications. Most patients achieve 5% weight loss within the first few months, with 89-91% of patients achieving this benchmark. Greater weight reductions of 10%, 15%, and even 20% are commonly achieved with proper medical supervision and lifestyle modifications.

Ideal candidates typically have a BMI of 30 or higher, or BMI of 27 with weight-related health conditions like diabetes or high blood pressure. Dr. Nawrocki evaluates each patient individually during consultation to determine candidacy for GLP-1 injection therapy based on health history, current medications, and weight loss goals.

The most common side effects are gastrointestinal and typically mild to moderate, including nausea, constipation, and decreased appetite. These side effects often diminish as your body adjusts to the medication. Our medical team provides guidance on managing any side effects and adjusts dosing as needed for optimal comfort and results.

Most patients begin experiencing appetite suppression within 1-2 weeks of starting treatment. Noticeable weight loss typically occurs within 4-6 weeks, with significant results becoming apparent after 3-4 months of consistent treatment with proper medical supervision.

GLP-1 medications are typically prescribed for long-term use to maintain weight loss benefits. Treatment duration varies by individual, but many patients continue therapy for 12-24 months or longer. Dr. Nawrocki works with each patient to determine the optimal treatment duration based on individual goals and health status.

Medical weight loss uses GLP-1 receptor agonists that mimic natural hormones to regulate appetite, slow digestion, and improve insulin sensitivity. These medications help you feel full longer, reduce food cravings, and make sustainable lifestyle changes easier to maintain with proper medical supervision.

FDA-approved GLP-1 medications are generally well-tolerated and safe when properly prescribed and monitored. Our comprehensive program includes regular follow-up appointments with Dr. Nawrocki to monitor progress, adjust dosages, manage any side effects, and ensure treatment safety throughout your weight loss journey.